Agoracom Blog Home

Posts Tagged ‘covid19’

Loop Insights $MTRX $RACMF Appoints Former Epson General Manager of Global Brand & Marketing Communications, Ian Cameron, as VP of Marketing to Support Loop’s Continued Global Expansion in 2021 $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 9:45 AM on Thursday, March 4th, 2021
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png
  • Announced the appointment Ian Cameron, former General Manager of Global Brand & Marketing Communications at Seiko Epson Corporation, as its VP of Marketing, effective March 15th, 2021
  • Ian Cameron is a global marketing, eCommerce, and brand executive with over 20 years of experience delivering positive business results for major companies, including Epson, a global printing equipment leader with a market cap of $US 5.73 billion

VANCOUVER, British Columbia, March 04, 2021 – Loop Insights Inc. (MTRX:TSXV RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing for the brick and mortar space, is pleased to announce the Company has appointed Ian Cameron, former General Manager of Global Brand & Marketing Communications at Seiko Epson Corporation, as its VP of Marketing, effective March 15th, 2021.

Cameron Joins Loop Insights After Establishing and Managing Epson’s Global Marketing Team

Ian Cameron is a global marketing, eCommerce, and brand executive with over 20 years of experience delivering positive business results for major companies, including Epson, a global printing equipment leader with a market cap of $US 5.73 billion.

Epson (an abbreviation for “Son of Electronic Printer”), is a Japanese electronics company and one of the world’s largest manufacturers of computer printers, and information and imaging-related equipment.

Loop Insights CEO Rob Anson stated: “Ian’s experience working with a global leader such as Epson speaks to the level of talent that Loop has been able to attract. As a global marketing and communications expert, Ian is another key strategic addition to our team. I look forward to working alongside Ian and witnessing his impact on our marketing efforts as Loop continues to position and prove itself as a global leader in the Artificial Intelligence and data applications space.”

Strong Executive Leadership Positions Loop to Continue to Accelerate Expansion for 2021

Under Cameron’s leadership, Epson centralized redundant regional activities increasing profitability significantly and improved their global digital user experience while saving millions of dollars annually for the company through a Global digital transformation project that unified multiple disparate regional content management, eCommerce, and product information systems.

Cameron’s experience in driving successful enterprise global marketing campaigns is expected to significantly contribute to continued growth and scale for Loop Insights in 2021.

Ian Cameron stated: “I am very excited to join the Loop team and to support and contribute to the growth of the company. Loop’s clear multifaceted value propositions are very exciting and as a marketing professional, the value of attribution, campaign performance, and the granularity of the data analytics that Loop is able to provide is simply unparalleled. Loop’s technology is something that marketers only wish for and dream of.”

On January 28th , Loop Insights appointed Tamer Shafik, the former Director of Solution Architecture at NTT Data Corp of Japan, as the company’s new Chief Technology Officer in support of Loop’s global scale. Shafik joined the company as a result of a flourishing partnership between Loop and NTT Data. Shafik’s immense experience and skillset have already made a significant impact with the Loop team, transforming the product department in a short amount of time.

Read More: https://agoracom.com/ir/LoopInsights/forums/discussion/topics/756557-loop-insights-appoints-former-epson-general-manager-of-global-brand-marketing-communications/messages/2306457#message

XPhyto Therapeutics $XPHY.ca $XPHYF Completes Corporate Rebranding and Launches New Website $NGM.ca $SONA.ca $HBP.ca $MIR.ca $IPA.ca

Posted by AGORACOM-Eric at 8:05 AM on Thursday, March 4th, 2021
http://blog.agoracom.com/wp-content/uploads/2021/01/XPHYTO-70-x-70.jpg
  • Rebranding Reflects XPhyto’s Commitment To Operational Achievement
  • Product Development Advance From The Lab To The Clinic
  • Cusp Of Two Major Commercial Milestones Related To Our Rapid Point-Of-Care COVID-19 PCR Test System
  • A Bioscience Accelerator At The Leading-Edge Of The Life Science Industry

XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”), is pleased to announce that the Company has completed a corporate rebranding and launched a new website which can be viewed at www.xphyto.com.

The rebranding decision reflects the Company’s commitment to operational achievement in 2021 as a number of product development programs advance from the laboratory to the clinic. As a bioscience accelerator at the leading-edge of the life science industry, XPhyto is targeting value creation through commercialization of its development pipeline and focused investment in impact driven innovation.

“The Company is excited to introduce a fresh look at such a pivotal point in our business growth,” said Hugh Rogers, CEO & Director of XPhyto. “With all technical requirements fulfilled, we are on the cusp of two major commercial milestones related to our rapid point-of-care COVID-19 PCR test system. With expected ISO certification and CE-IVD approval pending, we are excited to enter the next phase of our business with a positive, crisp and energetic new image.”

The Company will provide further information and updates in due course. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 pandemic. Further, its COVID-19 related test products are not yet approved and are still subject to risks associated with the regulatory approval process.

Read More: https://agoracom.com/ir/XphytoTherapeutics/forums/discussion/topics/756560-xphyto-completes-corporate-rebranding-and-launches-new-website/messages/2306460#message

Loop Insights $MTRX $RACMF Signs Letter of Intent for $2,000,000 Licensing Deal with Maitri Health Technologies to Combine #PPE, Artificial Intelligence and #Proptech In First-Ever Globally Scalable Offering $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 10:00 AM on Monday, March 1st, 2021
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png

Combination of Loop technologies with Maitri platform has potential to create new paradigm in $120 Billion PPE market.

  • Announced the signing of a letter of intent (LOI) for the grant of a non-exclusive license to Maitri Health Technologies Corp. (CSE: MTEC) for various aspects of Loop’s technology in return for CDN$2,000,000 in cash and common shares as well as a revenue-sharing arrangement.
  • Maitri Health Technologies is focused on modernizing healthcare systems for a post-pandemic world.
  • Global events in 2020 identified the need for long-term security in both healthcare and the workplace.

VANCOUVER, BC , March 1, 2021 – Loop Insights Inc. (TSXV: MTRX) (OTCQB: RACMF) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing to the brick and mortar space, is pleased to announce the signing of a letter of intent (LOI) for the grant of a non-exclusive license to Maitri Health Technologies Corp. (CSE: MTEC) for various aspects of Loop’s technology in return for CDN$2,000,000 in cash and common shares as well as a revenue-sharing arrangement.

Maitri Health Technologies is focused on modernizing healthcare systems for a post-pandemic world. Global events in 2020 identified the need for long-term security in both healthcare and the workplace. Maitri is a global platform for healthcare supply security providing a reliable source of certified PPE (personal protective equipment) and testing solutions through an onshore manufacturing model. This model has led to the creation of innovative and industry-leading products integrated with technology to help track, trace, and enable safer workplaces and communities. Maitri’s vision for the future is for safe workplaces and institutions to enable economies to operate uninterrupted.

The global market for PPE is expected to exceed USD$123 Billion by 2027 according to Grandview Research . The global workplace safety market is expected to grow to USD$19.9 Billion by 2025 according to Research and Markets .

The combination of Loop’s technologies with Maitri’s unique products has the potential to create a comprehensive offering for PPE and technology that will provide the foundation for safer, more protected workplaces and communities.

Loop Insights CEO Rob Anson stated: “COVID-19 created an immediate need for PPE that also immediately became a highly disorganized and fragmented market of middlemen and brokers with often questionable sources. Maitri’s ability to establish secure access and trusted distribution to key PPE products through a platform positions them to quickly become a strong force in the industry.  This licensing arrangement  will provide the ability to add venue, business and building protection to their offering, leading to brand new opportunities and revenue models.”

LICENSING ARRANGEMENT TO COMBINE PPE, ARTIFICIAL INTELLIGENCE AND PROPTECH IN FIRST-EVER AND FULLY SCALABLE OFFERING

Maitri’s PPE line of products combined with Loop Insights technology represents the convergence of a powerful PPE, AI, and Proptech offering that enables operators, businesses and building owners to reopen and protect all constituents with a documented process from verified PPE to venue management and artificial intelligence-driven marketing opportunities. This combined protocol enables physical buildings to fully reopen, generate revenue, and remain viable assets under end-to-end protection.

As a result, Loop Insights gains access to another major industry component that is essential to the safe re-opening of the global economy and society.

“Our relationship with Loop technology will create the opportunity to deliver a more complete safety protocol along with our existing products and offerings,” said Andrew Morton , CEO of Maitri. “We’re well-positioned to play a significant role supporting a path to global economic recovery.”

TERMS OF THE LOI

Loop will license the following technology:

  • AI Data Insights Portal;
  • SmarTap Check-in Technology; and
  • Digital Wallet Pass Technology.

In exchange for the license, Loop will receive a total value of $2,000,000 in a combination of both:

  • Cash $250,000 ;
  • Common Shares $1,750,000 ; and
  • Revenue Share (terms to be determined)

Both parties have agreed to a 30-day closing period for a definitive agreement, the terms of which are subject to the approval by the Board of Directors of both companies.

This Press Release Is Available On The Loop Insights Verified Forum On AGORACOM For Shareholder Discussion And Management Engagement https://agoracom.com/ir/LoopInsights/forums/discussion

About Maitri Health Technologies

Maitri Health Technologies Corp. (CSE: MTEC, FRA: D84) is a global platform for healthcare supply security. Our mission is to enhance safety and quality of life, and keep organizations and economies running. Maitri provides a reliable source of innovative, certified personal protective equipment and testing solutions through an onshore manufacturing model. Our stable, scalable supply chain is integrated with unique digital technology to deliver a comprehensive healthcare supply platform. For more information: https://maitrihealth.ca/ or in[email protected]

About Loop Insights

Loop Insights Inc. is a Vancouver -based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada , the US, the UK, Latin America , Australia , Japan , and Indonesia . Loop’s products and services are backed by Amazon’s Partner Network.

Read More: https://agoracom.com/ir/LoopInsights/forums/discussion/topics/756287-loop-insights-signs-letter-of-intent-for-2-000-000-licensing-deal-with-maitri-health-technologies-to-combine-ppe-artificial-intelligence/messages/2305880#message

VIDEO – Loop Insights Wallet Pass Platform Chosen To Engage Fans of WBC Championship Fight, Featuring Saul “Canelo” Álvarez and Avni Yildirim

Posted by AGORACOM-JC at 5:16 PM on Friday, February 26th, 2021
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png

The highly-anticipated championship fight, with the WBA (Super), WBC, and The Ring super middleweight titles all on the line, is being broadcast to over 200 countries. 

“WBC FAN PASS” ALLOWS WBC TO ENGAGE WORLDWIDE FANBASE, INCLUDING OVER 2 MILLION SOCIAL MEDIA FOLLOWERS AND OVER 10 MILLION COMBINED FOLLOWERS ON FIGHT NIGHT  

WBC President Maurico Sulaiman stated: “This premier fight featuring Saul “Canelo” Álvarez and Avni Yildirim provides the perfect opportunity for the WBC to leverage Loop’s Engagement platform to connect in real-time with our worldwide fanbase. Loop’s impressive capabilities will allow the WBC to deliver the right experience at the right time, all while retaining critical information as we continue to grow our fan base throughout 2021, the year of boxing.” 

Loop Insights’ automated engagement platform will revolutionize the fan onboarding experience for the WBC, enabling the seamless acquisition and activation of fans through the company’s Wallet pass technology. Click the link below to download your own personalized WBC Fan pass for this weekend’s event: https://goloop.ai/WBC-FanPass-IR

Sit back and watch this powerful interview.

Loop Insights $MTRX $RACMF Provides Wallet Pass Platform To World Boxing Council (WBC) To Engage Fans For Championship Fight Being Broadcast To Over 200 Countries $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 5:16 PM on Thursday, February 25th, 2021
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png
  • Announced an agreement with the World Boxing Council to provide Loop’s Wallet pass platform to engage with global boxing fans during the WBC super-middleweight championship fight, featuring champion Saul “Canelo” Álvarez and challenger Avni Yildirim, at Miami’s Hard Rock Stadium this Saturday, February 27th.

VANCOUVER, British Columbia, Feb. 25, 2021  — Loop Insights Inc. (MTRX:TSXV) (RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing to the brick and mortar space, is pleased to announce an agreement with the World Boxing Council to provide Loop’s Wallet pass platform to engage with global boxing fans during the WBC super-middleweight championship fight, featuring champion Saul “Canelo” Álvarez and challenger Avni Yildirim, at Miami’s Hard Rock Stadium this Saturday, February 27th.

The highly-anticipated championship fight, with the WBA (Super), WBC, and The Ring super middleweight titles all on the line, is being broadcast to over 200 countries.

The WBC is a world-class athletic organization often regarded as the most prestigious world title and has held some of the best high-profile fights ever watched in the history of Boxing.

WBC President Maurico Sulaiman stated: “This premier fight featuring Saul “Canelo” Álvarez and Avni Yildirim provides the perfect opportunity for the WBC to leverage Loop’s Engagement platform to connect in real-time with our worldwide fanbase. Loop’s impressive capabilities will allow the WBC to deliver the right experience at the right time, all while retaining critical information as we continue to grow our fan base throughout 2021, the year of boxing.”

Loop Insights CEO Rob Anson stated: “Working with the World Boxing Council is a great honour that will allow Loop Insights to demonstrate the power of its Engagement and Wallet pass platform at scale. Loop’s automated data capabilities will provide an enhanced layer of engagement and interaction by driving fans to the WBC’s social media channels, eCommerce platforms and driving new memberships in the WBC loyalty platform, creating new revenue streams for both Loop and the WBC. We believe this represents a paradigm shift in the global fight event vertical and expect to announce further partnerships in the near future.”

“WBC FAN PASS” ALLOWS WBC TO ENGAGE WORLDWIDE FANBASE, INCLUDING OVER 2 MILLION SOCIAL MEDIA FOLLOWERS AND OVER 10 MILLION COMBINED FOLLOWERS ON FIGHT NIGHT

Under the terms of the agreement, Loop will deploy its Engage platform to drive real-time engagement and omnichannel updates to the World Boxing Council’s global fanbase. In total, Saul “Canelo” Álvarez, challenger Avni Yildirim, and the WBC itself have over 10 million social media followers, providing Loop with a global scale opportunity to engage with fans from around the world while establishing scalable revenue streams.

Loop Insights’ automated engagement platform will revolutionize the fan onboarding experience for the WBC, enabling the seamless acquisition and activation of fans through the company’s Wallet pass technology. Click the link below to download your own personalized WBC Fan pass for this weekend’s event: https://goloop.ai/WBC-FanPass-IR

Once onboarded into Loop’s fan engagement platform, the WBC and its sponsors will gain direct access to fans through a WBC-branded Fan Pass built on the mobile wallet application found on most smartphones. This all-access pass will be updated to send omnichannel fight updates and promotions, including special offers through streaming partners DAZN and discounts via official merchandisers, including a reduced price on WBC branded merchandise sold via Title Boxing. The WBC Fan Pass is designed to display promotions and targeted marketing opportunities “above” the lock screen of any smartphone, allowing consumers to access their pass without the need for an additional application.

Loop’s fan engagement platform is designed to seamlessly guide customers through the entire path to purchase, increasing fan spend and revenues through:

  • Purchases made via Loop’s Fan Access pass
  • Revenue share opportunities through sponsored promotions

BEYOND FIGHT NIGHT ENGAGEMENT AND ACTIVATION
Following Álvarez versus Yildirim, Loop’s Fan Access pass will maintain a direct line of communication between the WBC and its fans, allowing the WBC to communicate directly to its global fan base through their smartphones.

This Press Release Is Available On The Loop Insights Verified Forum On AGORACOM For Shareholder Discussion And Management Engagement https://agoracom.com/ir/LoopInsights/forums/discussion

About the World Boxing Council

The World Boxing Council is Boxing’s elite sanctioning body and has as its maximum priority to work and protect athlete’s safety and health inside and outside of the boxing ring. The WBC was founded in 1963 and now comprises 165 countries from around the world. Some of their greatest champions include Muhammad Ali, Mike Tyson, Julio Cesar Chavez, Oscar de La Hoya, Sugar Ray Leonard, Floyd Mayweather, and Manny Pacquiao among others.

Empower Clinics $CBDT.ca $EPWCF Announces Locations of First Three Integrated Health Centres in Ontario. Each Location Anticipated to Generate Approximately $3,000,000 In Revenue. Further Locations to Be Announced $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 8:01 AM on Thursday, February 25th, 2021

Launch Confirms Empower Stated Strategy To Execute National Clinic Expansion Following Canadian Clinics Acquisition And Partnership Announcements in 2021

  • Announce the launch of its first three integrated health centres in Ontario, Canada with each location expected to generate $2,560,000 – $3,600,000 in annual revenue.
  • Advanced discussions are currently underway on multiple additional locations as the Company begins the rollout of its national clinic expansion strategy.

VANCOUVER, BC / February 25, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (8EC:Frankfurt) (EPWCF:OTCQB) (“Empower” or the “Company“) an integrated healthcare company serving patients through medical centres, telemedicine platforms, operating a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens, is pleased to announce the launch of its first three integrated health centres in Ontario, Canada with each location expected to generate $2,560,000 – $3,600,000 in annual revenue. Advanced discussions are currently underway on multiple additional locations as the Company begins the rollout of its national clinic expansion strategy.

THREE ONTARIO LOCATIONS AND TWELVE PHYSICIANS COMMITTED TO OPEN

The locations and approximate sizes of the integrated health centres are as follows:

1) Etobicoke, Ontario Approximately 2,700 sq ft.

2) London, Ontario Approximately 3,100 sq ft.

3) Etobicoke, ON (site two) Approximately 2,900 sq ft.

“Dr. Aviv Tsimmerman and Dr. Jordan Rabinowitz are executing on our growth initiatives, they are achieving milestones, they are opening our healthcare centers.” said Steven McAuley, Chairman & CEO. “Our approach is based on patients and their needs, the delivery of care, an improved healthcare model, that provides advanced technology and access for an improved healthcare outcome.”

Each location is expected to host 4-6 physicians. Empower has already secured commitments from twelve (12) physicians to date, with numerous additional medical doctors and para-medical practitioners expressing interest to join the team.

“Having a strategic blend of health professionals allows us to provide an unparalleled integrative healthcare experience.” stated Dr. Jordan Rabinowitz, Chief Operating Officer. He further states, “This defines our path to assist millions of Canadians nationwide.”

HEALTH CARE SERVICES TO BE DELIVERED AND ANTICIPATED REVENUE MODEL

Empower will be opening primary care, plus para-medical healthcare services, with a target of four (4) to six (6) medical doctors and four (4) to six (6) paramedical practitioners per location.

Primary care services include:

  • Family physicians
  • Walk-in physicians
  • Tele-medicine and virtual care

Empower expects to generate $400,000 – $600,000 in annual revenue per MD, per location, which equates to a revenue range between $1,600,000 – $2,400,000 annually per location.

Paramedical services include:

  • Chiropractic
  • Physiotherapy
  • Registered Massage Therapy
  • Chiropody
  • Acupuncturists
  • Osteopaths
  • Nutritionists

Empower expects to generate $960,000 – $1,200,000 in annual revenue per location.

Together, when each location is fully operational, Empower expects to generate $2,560,000 – $3,600,000 in annual revenue per location.

ADDITIONAL HEALTH CARE SERVICES EXPECTED TO BE ADDED

Given the anticipated expansion and penetration of Empower Clinics into the Canadian market, the Company intends to continue adding valuable specialized medical services to strengthen the quality of healthcare at each location that can include:

  • Dermatology
  • Cardiology

Empower is currently in advanced discussions with potential partners in each of these specialty areas and believes they hold the potential to add significant value to the operations of each healthcare centre.

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics

ABOUT EMPOWER:

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors:
Steven McAuley
CEO
[email protected]
604-789-2146

Investors:
Tamara Mason
Business Development & Communications
[email protected]
416-671-5617

Read more: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/756054-empower-clinics-announces-locations-of-first-three-integrated-health-centres-in-ontario-each-location-anticipated-to-generate-approximately-3m/messages/2305329#message

XPhyto Therapeutics $XPHY.ca $XPHYF Places First Order for 25-Minute Covid-19 RT-PCR Tests $NGM.ca $SONA.ca $HBP.ca $MIR.ca $IPA.ca

Posted by AGORACOM-Eric at 8:05 AM on Wednesday, February 24th, 2021
This image has an empty alt attribute; its file name is XPHYTO-70-x-70.jpg
  • Placed First Order for its Rapid Point-Of-Care COVID-19 Test System
  • 9600 Individual Tests Ordered
  • Mid-March Delivery
  • Additional Pandemic-Focused Biosensors in Development

XPhyto Therapeutics. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company“), is pleased to announce that it has placed the first order for its rapid point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system (“Covid-ID Lab”) from its exclusive diagnostic development partner, 3a-diagnostics GmbH (“3a”).

The first order of Covid-ID Lab is for 9,600 individual tests, which are packaged in 200 kits of 48 tests each. Delivery of the first order is expected by mid-March 2021 and will be primarily used to supply prospective distribution partners and licensees and their respective government regulators with test samples for review and evaluation. The tests will be manufactured in the German state of Baden-Württemberg.

“We are pleased to report that all steps towards the launch of Covid-ID Lab remain on track within an ambitious timeline,” said Hugh Rogers, CEO, and Director of XPhyto. “Our experienced market launch team is working quickly to bring the product to market, as well as to establish licensing and distribution partnerships. We are confident that Covid-ID Lab, as a 25-minute PCR test with minimal technical and personnel requirements, will be a stand-out product in the COVID-19 test market.”

Covid-ID Lab was designed to be a rapid, accurate, and robust COVID-19 test system with reduced operating costs and increased convenience and portability. XPhyto expects 3a to receive ISO 13485 medical device manufacturer approval by the end of February and European regulatory approval as a commercial in vitro diagnostic device (CE-IVD) for Covid-ID Lab by early March. Initial commercial manufacturing is planned for Germany, with additional capacity in other jurisdictions to follow. The sales launch in Europe is targeted for April 2021. XPhyto is currently in discussions with potential distribution and wholesale partners in Europe and the Middle East.

XPhyto and 3a are also developing a portfolio of oral biosensor screening tests for detection of bacterial and viral infectious diseases, including influenza A, group A strep, stomatitis, periimplantitis, and periodontitis. Additional pandemic-focused biosensors are in development, specifically for H1N1 (swine flu) and H5N1 (avian flu). The Company is planning the commercial launch of its first biosensor product in the second half of 2021.

Read More: https://agoracom.com/ir/XphytoTherapeutics/forums/discussion/topics/755962-xphyto-places-first-order-for-25-minute-covid-19-rt-pcr-tests/messages/2305102#message

XPhyto Therapeutics $XPHY.ca $XPHYF Builds Commercial Team to Launch 25-Minute Covid-19 Test $NGM.ca $SONA.ca $HBP.ca $MIR.ca $IPA.ca

Posted by AGORACOM-Eric at 8:32 AM on Monday, February 22nd, 2021
  • Expedited formation of commercial team to launch its point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system
  • Expects medical device manufacturer approval by the end of February
  • European regulatory approval as a commercial in vitro diagnostic device by early March.

XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) (“XPhyto” or the “Company“), is pleased to announce that the Company has expedited the formation of an experienced commercial team to launch its point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system (“Covid-ID Lab”). Covid-ID Lab was developed by XPhyto’s exclusive German diagnostics development partner, 3a-diagnostics GmbH (“3a”). XPhyto expects 3a to receive ISO 13485 medical device manufacturer approval by the end of February and European regulatory approval as a commercial in vitro diagnostic device (CE-IVD) for Covid-ID Lab by early March.

The market launch team consists of world-class clinical and pharmaceutical executives and service providers who bring the experience and expertise necessary to effectively and rapidly drive the commercialization of Covid-ID Lab. Collectively, the team brings decades of experience in the biotech and pharmaceutical industries, including: executive leadership, business development, regulatory compliance, product launch, international marketing and sales, production, quality assurance, and M&A. In particular, members of the team have led medical diagnostic company growth from inception to over 500 million Euro per year in multinational sales.

“We are extremely fortunate to now have a team with deep expertise in medical diagnostic product commercialization. The team has extensive experience from regulatory approval to international production and sales,” said Hugh Rogers, CEO and Director of XPhyto. “As we near expected regulatory approval, XPhyto’s business is rapidly evolving from innovation to impact. We are working hard to put the Company in the best possible position to execute on our business strategy.”

Read More: https://agoracom.com/ir/XphytoTherapeutics/forums/discussion/topics/755782-xphyto-builds-commercial-team-to-launch-25-minute-covid-19-rt-pcr-test/messages/2304693#message

VIDEO – As Empower Clinics $CBDT.ca $EPWCF Makes New Highs On Multiple Major Announcements, CEO McAuley Discusses Why $100M Clinic Revenue Is Stage 1 – And Much More Is Coming $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 5:27 PM on Thursday, February 18th, 2021

When we conduct a “Beyond The Press Release” interview, it is always about A press release …. but Empower Clinics has been moving so fast that we sat down with CEO Steve McAuley to discuss these THREE press releases, the explosive growth of the Company and where it is going:

  • Partnership With Rexall To Launch Integrated Health Centres
  • Surpassed 1,000 COVID-19 tests on 1 day for first time ever … 3X Lab Expansion
  • Secured Medical Device Establishment License (MDEL) To Sell KAI Saliva

As usual, Six Sigma Steve McAuley doesn’t disappoint as he confidently and clearly tells investors where Empower Clinics is going next.

Empower Clinics $CBDT.ca $EPWCF KAI Medical Laboratory Demonstrates Significant Scientific Capability by Validating its PCR Tests Accurately Detect COVID-19 U.K. and South Africa Variants $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 8:31 AM on Thursday, February 18th, 2021

Kai Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas, TX was acquired by Empower Clinics on October 6, 2020 to further advance the Company’s COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses and travel industry

  • Announced KAI Medical Laboratory has validated that its various COVID-19 PCR test products are able to accurately detect the B.1.1.7 (UK variant) & B.1.351 (South African variant)

VANCOUVER BC / February 18, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(OTCQB:EPWCF)(Frankfurt:8EC) (“Empower” or the “Company“) an integrated healthcare company serving patients through medical centres, telemedicine platforms, operating a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens, is pleased to announce our KAI Medical Laboratory (“KAI LAB”) has validated that its various COVID-19 PCR test products are able to accurately detect the B.1.1.7 (UK variant) & B.1.351 (South African variant).

“The Kai Labs motto of Inspire by Science, Built on Integrity is displayed so accurately as the team of molecular scientists took it upon themselves to validate our test protocols against pervasive new COVID-19 variants.” said Steven McAuley, Chairman & CEO. “Leading with science, continuous improvement and a desire to impact healthcare outcomes elevates Kai Labs to a national and international stage. I expect this to be a competitive advantage as we endeavour to sign new global distribution and sales contracts.”

World Health Organization (WHO) Chief Scientist Confirms The U.K. Variant and South African Variants Are a Concern

Dr. Soumya Swaminathan comments “…scientists have now studied this and have found that these variants do tend to spread faster, they’re more transmissible or more infectious. So that’s the worrying part.”

KAI Medical Laboratory Research & Development a key differentiator for the Future

The KAI Lab testing protocol tests for parts of the viral genome that is not affected by the mutations in the spike protein the “S’ gene. In effect, this ensures the active virus in a patient’s RNA genetic sequence can be detected and a correct test result will be provided.

Dr. Soumya Swaminathan indicates “We know that testing, that identifying those who are infectious, that being able to provide them supportive isolation, tracking and contact tracing, and quarantining all the contacts…All of these things together definitely make a difference in bringing down transmission.”

Read More: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/755571-empower-clinics-kai-medical-laboratory-demonstrates-significant-scientific-capability-by-validating-its-pcr-tests-accurately-detect-covid-19-u-k/messages/2304168#message